Last reviewed · How we verify
NCT05920460
Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women
NA trial testing Cognitive Behavioral Therapy Program in Depression in 88 participants. Completed in 29 September 2022.
30 August 2022
Quick facts
| Lead sponsor | Beni-Suef University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 88 |
| Start date | 15 June 2022 |
| Primary completion | 30 August 2022 |
| Estimated completion | 29 September 2022 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Cognitive Behavioral Therapy Program
Conditions studied
- Depression — all drugs for Depression →
- Insomnia — all drugs for Insomnia →
- Cognitive Behavioral Therapy — all drugs for Cognitive Behavioral Therapy →
- Menopausal Depression — all drugs for Menopausal Depression →
Sponsor
Beni-Suef University
Who can join
Adults 40 to 55, any sex, with Depression or Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Considering physical and psychological problems that threaten women during the menopausal period, it seems that therapies that can help women cope with these problems, especially psychological ones, will be useful. The community mental health nurse is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the primary health care nurse to know how to properly approach women at this stage of their life and how to provide them the best and safe treatment. Because only limited interventional studies have been done to manage insomnia and depression among menopausal women in Egypt, the present study focused on reducing and insomnia and depression of menopausal women by using group Cognitive behavioral therapy. The current study aimed to examine the efficiency of group Cognitive Behavioral Therapy for insomnia and depression among menopausal women.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Does a program-based cognitive behavioral therapy affect insomnia and depression in menopausal women? A randomized controlled trial.
El-Monshed AH, Khonji LM, Altheeb M, Saad MTE, et al · · 2024 · cited 5× · PMID 38329153 · DOI 10.1111/wvn.12707
Verify or expand the search:
- PubMed search for NCT05920460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Beni-Suef University trials
Trials by the same sponsor.
- NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
- NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
- NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
- NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05920460 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
- Last refreshed: 27 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05920460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing